You are here

  • Home
  • Archive
  • Volume 21, Issue 5
  • Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes

Article Text

Article menu
Download PDFPDF
Therapeutics/Prevention
Systematic review with meta analysis
Erythropoietin corrects anaemia and reduces the risk of blood transfusion in people with chronic kidney disease, but has uncertain effects on other patient-level outcomes

http://dx.doi.org/10.1136/ebmed-2016-110418

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interests DWJ has previously received consultancy fees, research grants, speaker's honoraria and travel sponsorships from Amgen, Roche and Janssen-Cilag.

    • Provenance and peer review Commissioned; internally peer reviewed.